This case highlights the critical need for a high index of suspicion for EuDKA in patients taking SGLT2 inhibitors, even with only modest hyperglycemia, and underscores the importance of prompt intervention, including consideration of early hemodialysis, when standard therapies for metabolic acidosis fail. This evidence concerns the gene SLC5A2 and metabolic acidosis.